NR4A1 and breast carcinoma: Advanced methods used to detect, diagnose and stage breast cancer. These services go beyond standard clinical exams and may include imaging techniques (e.g., mammography, ultrasound and MRI), biopsy procedures (e.g., fine needle aspiration or core biopsy) and molecular testing (e.g., genetic markers, hormone receptor status) to assess the type, stage and genetic profile of a tumour. Specialized diagnostic services are critical for tailoring personalized treatment plans and improving patient outcomes.